经导管或外科二尖瓣修复对二尖瓣脱垂患者心律失常负荷的影响
单中心回顾性队列研究纳入1911例二尖瓣修复或TEER患者,其中154例符合AMVP标准。外科修复后AMVP与非AMVP患者NSVT、VT及ICD植入率相似,而TEER后AMVP患者NSVT、VT及ICD植入率显著更高;外科修复后PVC负荷下降,TEER后无变化。
要点
- 外科二尖瓣修复后AMVP患者室性心律失常负荷与非AMVP患者相似。
- TEER后AMVP患者NSVT、VT及ICD植入率显著高于非AMVP患者。
- 外科修复后PVC负荷下降,TEER后PVC负荷无变化。
核心结论
- 外科二尖瓣修复与AMVP患者心律失常负荷降低相关,而TEER与持续性室性心律失常升高相关。
研究设计与样本
- 单中心回顾性队列研究,纳入2004至2024年间接受外科二尖瓣修复或TEER的1911例患者。
- AMVP按EHRA/ESC标准定义,要求二尖瓣脱垂伴频发(PVC负荷≥5%)或复杂室性心律失常且无其他心律失常基质。
主要发现
- 154例AMVP患者中,109例(71%)接受外科修复,45例(29%)接受TEER。
- 外科修复后,AMVP与非AMVP患者NSVT(18% vs 13%)、VT(3.7% vs 3.6%)及ICD植入(3.7% vs 3.7%)率相似。
- TEER后,AMVP患者NSVT(33% vs 7%,P < 0.01)、VT(12% vs 2.6%,P = 0.01)及ICD植入(4.7% vs 0%,P = 0.02)率显著更高。
- 外科修复后PVC负荷从1.1%降至0.5%(P < 0.001),TEER后PVC负荷无变化。
- AMVP患者死亡率更高但无统计学显著性。
临床怎么用
- 对AMVP患者选择修复方式时,可考虑优先选择外科二尖瓣修复以降低心律失常负荷。
- TEER后AMVP患者需加强室性心律失常监测。
局限性
- 回顾性单中心设计,AMVP患者样本量较小(154例),TEER组仅45例。
- 死亡率差异无统计学显著性,需前瞻性研究比较不同修复方式的心律失常结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Arrhythmic mitral valve prolapse (AMVP) is associated with malignant ventricular arrhythmias, yet the impact of surgical repair versus transcatheter edge-to-edge repair (TEER) on arrhythmic outcomes remains unclear. We evaluated ventricular arrhythmia occurrence and premature ventricular contraction (PVC) burden following mitral repair in patients with and without AMVP. METHODS: We conducted a retrospective cohort study of 1911 patients who underwent surgical mitral valve repair or TEER between 2004 and 2024 at a single institution. AMVP was defined per EHRA/ESC criteria, requiring mitral valve prolapse with frequent (≥5% PVC burden) or complex ventricular arrhythmias and no alternative arrhythmic substrate. Outcomes included non-sustained ventricular tachycardia (NSVT), ventricular tachycardia (VT), implantable cardioverter-defibrillator (ICD) implantation, mortality, and changes in PVC burden in patients with pre- and post-procedural rhythm monitoring. RESULTS: Among 154 patients with AMVP, 109 (71%) underwent surgical repair and 45 (29%) underwent TEER. Following surgical repair, patients with AMVP had similar rates of NSVT (18% vs 13%), VT (3.7% vs 3.6%), and ICD implantation (3.7% vs 3.7%) compared with non-AMVP patients. In contrast, after TEER, patients with AMVP experienced significantly higher NSVT (33% vs 7%, P < 0.01), VT (12% vs 2.6%, P = 0.01), and ICD implantation (4.7% vs 0%, P = 0.02). PVC burden decreased after surgical repair (1.1% to 0.5%, P < 0.001) but remained unchanged after TEER. Mortality was higher in AMVP but not statistically significant. CONCLUSIONS: Surgical mitral repair is associated with reduced arrhythmic burden in AMVP, whereas TEER is associated with persistently elevated ventricular arrhythmias. These findings support phenotype-guided repair strategies and underscore the need for prospective studies comparing arrhythmic outcomes across repair modalities.
引用
- Sharew B, Sallam A, Razavi AA, et al. Impact of Transcatheter or Surgical Mitral Repair on Arrhythmic Burden in Patients With Mitral Valve Prolapse. Eur J Cardiothorac Surg. 2026. PMID: 42136200. doi:10.1093/ejcts/ezag131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。